Andreas-Claudius Hoffmann

1.9k total citations
53 papers, 1.3k citations indexed

About

Andreas-Claudius Hoffmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Andreas-Claudius Hoffmann has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Andreas-Claudius Hoffmann's work include Cancer Cells and Metastasis (13 papers), Cancer Genomics and Diagnostics (11 papers) and Lung Cancer Treatments and Mutations (9 papers). Andreas-Claudius Hoffmann is often cited by papers focused on Cancer Cells and Metastasis (13 papers), Cancer Genomics and Diagnostics (11 papers) and Lung Cancer Treatments and Mutations (9 papers). Andreas-Claudius Hoffmann collaborates with scholars based in Germany, Switzerland and United States. Andreas-Claudius Hoffmann's co-authors include Ivonne Nel, Peter V. Danenberg, Kathleen D. Danenberg, JF Schlaak, Daniel Vallböhmer, Ralf Metzger, Barbara Sitek, Hideo A. Baba, Helmut E. Meyer and Frank Weber and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Andreas-Claudius Hoffmann

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas-Claudius Hoffmann Germany 22 584 574 440 302 298 53 1.3k
Francisco Mansilla Denmark 20 291 0.5× 809 1.4× 276 0.6× 258 0.9× 169 0.6× 36 1.2k
Derya Duranyıldız Türkiye 22 662 1.1× 603 1.1× 294 0.7× 110 0.4× 234 0.8× 85 1.4k
Omar M. Rashid United States 25 738 1.3× 786 1.4× 450 1.0× 241 0.8× 415 1.4× 68 1.7k
Aparna Jayachandran Australia 18 426 0.7× 626 1.1× 271 0.6× 86 0.3× 201 0.7× 39 1.2k
Katsumi Koshikawa Japan 16 675 1.2× 921 1.6× 289 0.7× 237 0.8× 316 1.1× 31 1.5k
Marie‐Pierre Simon France 21 429 0.7× 1.1k 1.9× 555 1.3× 259 0.9× 439 1.5× 31 1.9k
Seiichi Shinji Japan 18 698 1.2× 377 0.7× 361 0.8× 308 1.0× 229 0.8× 107 1.2k
Tatsuhiro Yoshiki Japan 21 246 0.4× 550 1.0× 245 0.6× 248 0.8× 314 1.1× 68 1.3k
H-J Lenz United States 13 908 1.6× 603 1.1× 228 0.5× 159 0.5× 253 0.8× 21 1.4k
Armelle Degeorges France 18 776 1.3× 747 1.3× 562 1.3× 70 0.2× 404 1.4× 34 1.6k

Countries citing papers authored by Andreas-Claudius Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Andreas-Claudius Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas-Claudius Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas-Claudius Hoffmann more than expected).

Fields of papers citing papers by Andreas-Claudius Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas-Claudius Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas-Claudius Hoffmann. The network helps show where Andreas-Claudius Hoffmann may publish in the future.

Co-authorship network of co-authors of Andreas-Claudius Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas-Claudius Hoffmann. A scholar is included among the top collaborators of Andreas-Claudius Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas-Claudius Hoffmann. Andreas-Claudius Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goebel, Juliane, et al.. (2017). Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria. Journal of Cancer Research and Clinical Oncology. 143(12). 2527–2533. 13 indexed citations
2.
Nel, Ivonne, Thomas Gauler, Lazaros Lazaridis, et al.. (2016). Circulating Tumor Cell Composition in Renal Cell Carcinoma. PLoS ONE. 11(4). e0153018–e0153018. 38 indexed citations
3.
Bertram, Stefanie, Julia Kälsch, Maike Ahrens, et al.. (2016). Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions. Journal of Clinical Pathology. 69(7). 619–626. 12 indexed citations
4.
Megger, Dominik A., Thilo Bracht, Henning Reis, et al.. (2014). Identification of Novel Biomarker Candidates for the Immunohistochemical Diagnosis of Cholangiocellular Carcinoma. Molecular & Cellular Proteomics. 13(10). 2661–2672. 32 indexed citations
5.
Nel, Ivonne, et al.. (2014). Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC). PLoS ONE. 9(12). e113706–e113706. 36 indexed citations
6.
Barr, Martin P., Steven G. Gray, Andreas-Claudius Hoffmann, et al.. (2013). Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature. PLoS ONE. 8(1). e54193–e54193. 14 indexed citations
7.
Nel, Ivonne, Hideo A. Baba, Judith Ertle, et al.. (2013). Individual Profiling of Circulating Tumor Cell Composition and Therapeutic Outcome in Patients with Hepatocellular Carcinoma. Translational Oncology. 6(4). 420–428. 45 indexed citations
8.
Megger, Dominik A., Thilo Bracht, Michael Kohl, et al.. (2013). Proteomic Differences Between Hepatocellular Carcinoma and Nontumorous Liver Tissue Investigated by a Combined Gel-based and Label-free Quantitative Proteomics Study. Molecular & Cellular Proteomics. 12(7). 2006–2020. 99 indexed citations
9.
Kohl, Michael, Dominik A. Megger, Martin Trippler, et al.. (2013). A practical data processing workflow for multi-OMICS projects. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844(1). 52–62. 43 indexed citations
10.
Christoph, Daniel C., Andreas-Claudius Hoffmann, Thomas Gauler, et al.. (2012). Detection of Circulating Lung Cancer Cells with Strong Thymidylate Synthase Reactivity in the Peripheral Blood of a Patient with Pulmonary Adenocarcinoma Treated with Pemetrexed. Journal of Thoracic Oncology. 7(4). 766–767. 7 indexed citations
11.
Hoffmann, Andreas-Claudius, Peter J. Wild, Simone Bertz, et al.. (2010). MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy. Neoplasia. 12(8). 628–636. 106 indexed citations
12.
Hoffmann, Andreas-Claudius, Jussuf T. Kaifi, Daniel Vallböhmer, et al.. (2009). Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non‐small cell lung cancer. Journal of Surgical Oncology. 100(5). 414–417. 23 indexed citations
13.
Grimminger, Peter, Daniel Vallböhmer, Andreas-Claudius Hoffmann, et al.. (2009). Quantitative analysis of Survivin RNA expression in blood as a non‐invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer. Journal of Surgical Oncology. 100(6). 447–451. 10 indexed citations
14.
Hoffmann, Andreas-Claudius, Jan Brabender, Ralf Metzger, et al.. (2009). Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection. Journal of Surgical Oncology. 99(5). 296–301. 2 indexed citations
15.
Brabender, Jan, Daniel Vallböhmer, Peter Grimminger, et al.. (2008). ERCC1 RNA Expression in Peripheral Blood Predicts Minor Histopathological Response to Neoadjuvant Radio-chemotherapy in Patients with Locally Advanced Cancer of the Esophagus. Journal of Gastrointestinal Surgery. 12(11). 1815–1821. 32 indexed citations
16.
Hoffmann, Andreas-Claudius, Rintaro Mori, Daniel Vallböhmer, et al.. (2008). High Expression of Heparanase is Significantly Associated with Dedifferentiation and Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA and Via HIF1a to HB-EGF and bFGF. Journal of Gastrointestinal Surgery. 12(10). 1674–1682. 36 indexed citations
17.
Hoffmann, Andreas-Claudius, Rintaro Mori, Daniel Vallböhmer, et al.. (2008). High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF. Neoplasia. 10(7). 674–679. 123 indexed citations
18.
Jeger, Raban, et al.. (2007). Benefit of outpatient cardiac rehabilitation in under-represented patient subgroups. Acta Dermato Venereologica. 39(3). 246–251. 19 indexed citations
19.
Hoffmann, Andreas-Claudius, Ute Warnecke‐Eberz, T. Luebke, et al.. (2006). Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers. Journal of Surgical Oncology. 95(1). 51–54. 27 indexed citations
20.
Hoffmann, Andreas-Claudius, Élisabeth Van Gessel, Zdravko Gamulin, J E Ryser, & Alain Forster. (1995). Quantitative evaluation of tourniquet leak during i.v. regional anaesthesia of the upper and lower limbs in human volunteers. British Journal of Anaesthesia. 75(3). 269–273. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026